Kailera Therapeutics, Inc. (KLRA)

16.23 +0.49 (+3.11%) USD  |  NASDAQ  |  Sep 04, 16:00
16.24 +0.01 (+0.06%) After-Hours: 20:00
More

Kailera Therapeutics PS Ratio (Forward)

PS Ratio (Forward) Chart

View PS Ratio (Forward) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio (Forward) Chart
Start Trial

Historical PS Ratio (Forward) Data

View and export this data back to . Start Trial.
Date Value
September 04, 2026 --

Forward PS Ratio Definition

Forward Price to Sales Ratio is the current stock price over the predicted sales per share. While similar to the price to sales ratio, this is a forward looking estimate of a company's sales.

Read full definition.

PS Ratio (Forward) Range, Past 5 Years

View PS Ratio (Forward) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio (Forward) Benchmarks

View PS Ratio (Forward) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Sana Biotechnology, Inc. --
Parabilis Medicines, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade